Hawkinson J E, Drewe J A, Kimbrough C L, Chen J S, Hogenkamp D J, Lan N C, Gee K W, Shen K Z, Whittemore E R, Woodward R M
CoCensys, Inc., Irvine, California 92718, USA.
Mol Pharmacol. 1996 May;49(5):897-906.
Neuroactive steroids bind to a unique site on the gamma-aminobutyric acidA (GABAA) receptor complex and allosterically modulate the binding of convulsant ([35S]t-butylbicyclophosphorothionate, [35S]TBPS), GABA ([3H]muscimol), and benzodiazepine ([3H]flunitrazepam) site ligands. In rat cortical membranes, 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha, 5 alpha-P) is a full agonist at the steroid site, inhibiting 96% of specific [35S]TBPS binding and enhancing [3H]flunitrazepam and [3H]muscimol binding 95% and 69% above control levels, respectively. In contrast, the synthetic steroid 3 alpha-hydroxy-3 beta-trifluoromethyl-5 alpha-pregnan-20-one (Co 2-1970) has limited efficacy for modulating the binding of [35S]TBPS (44% inhibition), [3H]flunitrazepam (41% enhancement), and [3H]muscimol (< 10% enhancement). In competition experiments, Co 2-1970 (10 microM) reduced the apparent potency of 3 alpha, 5 alpha-P by 7-17-fold for modulating the binding of these radioligands in rat cortical membranes, suggesting that it has partial agonist properties. Because cortical membranes contain a heterogeneous population of receptors, Co 2-1970 was examined in recombinant GABAA receptors stably expressed in human embryonic kidney 293 cells. Co 2-1970 inhibited [35S]TBPS binding with limited efficacy (39-65% inhibition) in the five receptor combinations examined and, at 10 microM, reduced the apparent potency of 3 alpha, 5 alpha-P 57-fold for inhibiting [35S]TBPS binding to alpha 1 beta 1 gamma 2L receptors. To verify these findings functionally, the effects of 3 alpha, 5 alpha-P and Co 2-1970 were examined electrophysiologically in Xenopus oo-cytes expressing alpha 1 beta 1 gamma 2L receptors. Co 2-1970 showed limited efficacy potentiation of GABA-evoked chloride currents relative to 3 alpha, 5 alpha-P (28% and 86% of the GABA maximum current, respectively). Moreover, Co 2-1970 produced a concentration-dependent antagonism of the 3 alpha, 5 alpha-P-induced potentiation that was associated with a reduction in the apparent affinity of 3 alpha, 5 alpha-P (11-fold at 10 microM Co 2-1970). Taken together, these data indicate that Co 2-1970 is a partial agonist at the neuroactive steroid site associated with GABAA receptors.
神经活性甾体与γ-氨基丁酸A(GABAA)受体复合物上的一个独特位点结合,并通过变构调节惊厥剂([35S]叔丁基双环磷硫代酸盐,[35S]TBPS)、GABA([3H]蝇蕈醇)和苯二氮䓬([3H]氟硝西泮)位点配体的结合。在大鼠皮质膜中,3α-羟基-5α-孕烷-20-酮(3α,5α-P)是甾体位点的完全激动剂,可抑制96%的特异性[35S]TBPS结合,并分别使[3H]氟硝西泮和[3H]蝇蕈醇的结合比对照水平提高95%和69%。相比之下,合成甾体3α-羟基-3β-三氟甲基-5α-孕烷-20-酮(Co 2-1970)调节[35S]TBPS结合(44%抑制)、[3H]氟硝西泮结合(41%增强)和[3H]蝇蕈醇结合(< 10%增强)的效力有限。在竞争实验中,Co 2-1970(10μM)使3α,5α-P调节大鼠皮质膜中这些放射性配体结合的表观效力降低了7至17倍,表明它具有部分激动剂特性。由于皮质膜含有异质性的受体群体,因此在稳定表达于人类胚胎肾293细胞中的重组GABAA受体中对Co 2-1970进行了检测。在检测的五种受体组合中,Co 2-1970抑制[35S]TBPS结合的效力有限(39 - 65%抑制),并且在10μM时,使3α,5α-P抑制[35S]TBPS与α1β1γ2L受体结合的表观效力降低了57倍。为了从功能上验证这些发现,在表达α1β1γ2L受体的非洲爪蟾卵母细胞中通过电生理学方法检测了3α,5α-P和Co 2-1970的作用。相对于3α,5α-P,Co 2-1970对GABA诱发的氯离子电流的增强效力有限(分别为GABA最大电流的28%和86%)。此外,Co 2-1970对3α,5α-P诱导的增强作用产生浓度依赖性拮抗,这与3α,5α-P的表观亲和力降低有关(在10μM Co 2-1970时降低11倍)。综上所述,这些数据表明Co 2-1970是与GABAA受体相关联的神经活性甾体位点的部分激动剂。